Recent findings published by The American Journal of Managed Care® highlight the benefits of using clascoterone in combination with adapalene for effective acne control. The study reveals that this combination therapy significantly improves acne outcomes, offering a promising alternative to traditional treatments. Clascoterone, a novel hormonal therapy, works by targeting androgen receptors, while adapalene, a well-known retinoid, reduces inflammation and promotes clearer skin. Together, these agents provide comprehensive acne management by addressing both hormonal and inflammatory components of acne. Patients noticed visible improvements in skin texture and reduced acne lesions, showcasing the potential of this regimen as a preferred approach for those struggling with acne. This breakthrough underscores the advancement in dermatological treatments and the ongoing quest for innovation in acne care.
The American Journal of Managed Care® (AJMC®)New data shows smarter solutions to change-of-mind returns as retailers crack down
August 3, 2026
In a bid to address the rising costs associated with change-of-mind returns, many retailers are implementing stricter policies. However, recent data suggests that a more